LENZ LENZ Therapeutics, Inc.
Healthcare$7.77+0.00%OpenMarket Cap: $243.6M
As of 2026-05-26
Valuation
P/E (TTM)
—
PEG
—
P/B
0.96
P/S
11.28
EV/EBITDA
-1.80
DCF Value
$2.43
FCF Yield
-36.9%
Div Yield
0.0%
Margins & Returns
Gross Margin
91.2%
Operating Margin
-563.8%
Net Margin
-519.3%
ROE
-46.8%
ROA
-40.0%
ROIC
-48.0%
Income Statement
Periods shown are fiscal year quarters (may differ from calendar year)
| Period | Revenue | Gross Margin | Operating Income | Net Income | EPS | Dividend |
|---|---|---|---|---|---|---|
| Q1 null | $1.9M | 37.6% | $-44.1M | $-41.5M | $— | — |
| Q4 null | $1.6M | 66.9% | $-38.5M | $-35.9M | $— | — |
| FY null | $19.1M | 96.3% | $-91.1M | $-82.1M | $— | — |
| Q3 null | $12.5M | 99.0% | $-18.9M | $-16.7M | $— | — |
| Q2 null | $5.0M | 99.6% | $-16.9M | $-14.9M | $— | — |
| Q1 null | $0.00 | -Infinity% | $-16.9M | $-14.6M | $— | — |
| Q4 null | $0.00 | NaN% | $-15.2M | $-12.7M | $— | — |
| FY null | $0.00 | -Infinity% | $-58.6M | $-49.8M | $— | $2.06 |
| Q3 null | $0.00 | NaN% | $-12.9M | $-10.2M | $— | — |
| Q2 null | $0.00 | NaN% | $-14.4M | $-10.3M | $— | — |
| Q1 null | $0.00 | NaN% | $-16.1M | $-16.6M | $— | $2.06 |
| Q4 2023 | $0.00 | NaN% | $-25.0M | $-23.7M | $-2.77 | — |